What are the consensus estimates for SATELLOS BIOSCIENCE INC (MSCL.CA) next earnings?
The consensus EPS estimate for the next earnings of SATELLOS BIOSCIENCE INC (MSCL.CA) is -0.01 CAD and the consensus revenue estimate is 0 CAD.
SATELLOS BIOSCIENCE INC (MSCL.CA) Forecast, Price Target & Analyst Ratings
TSX-V:MSCL • CA80401L8033
Current stock price
9.77 CAD
-0.35 (-3.46%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SATELLOS BIOSCIENCE INC (MSCL.CA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q4 / 2023
- EPS Estimate
- -CA$0.01
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of CA$9.77 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.71%
MSCL.CA was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about MSCL.CA.
In the previous month the buy percentage consensus was at a similar level.
MSCL.CA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q4 / 2023
- EPS Estimate
- -CA$0.01
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 72.55%
- Number of Analysts
- 2
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
Full Analyst Estimates 2023 - 2025
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | ||||||||
| EBITDA YoY % growth | -1.632M | -1.45M 11.18% | -2.2M -51.75% | -2.203M -0.11% | -1.653M 24.97% | -4.688M -183.70% | -8.074M -72.22% | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.66M | -1.473M 11.23% | -2.202M -49.44% | -2.206M -0.18% | -1.656M 24.94% | -4.854M -193.18% | -8.411M -73.28% | N/A -35.43% | N/A 12.32% | N/A -5.48% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A 43.86% | N/A 40.18% | N/A |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 23 | |
|---|---|
| EPS Q2Q % growth | -0.01 72.55% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -1.921M 11.56% |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
SATELLOS BIOSCIENCE INC / MSCL.CA Forecast FAQ
What is the consensus rating for SATELLOS BIOSCIENCE INC (MSCL.CA) stock?
The consensus rating for SATELLOS BIOSCIENCE INC (MSCL.CA) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.